{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T17:01:34Z","timestamp":1778518894683,"version":"3.51.4"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Biochemistry"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.clinbiochem.2021.01.008","type":"journal-article","created":{"date-parts":[[2021,2,2]],"date-time":"2021-02-02T13:53:31Z","timestamp":1612274011000},"page":"28-33","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Uncommon antinuclear antibody patterns as diagnostic indicators"],"prefix":"10.1016","volume":"90","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6808-6176","authenticated-orcid":false,"given":"Rachita","family":"Nanda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7828-2437","authenticated-orcid":false,"given":"Prishni","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7449-1354","authenticated-orcid":false,"given":"Suprava","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seema","family":"Shah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eli","family":"Mohapatra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"34","key":"10.1016\/j.clinbiochem.2021.01.008_b0005","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000011727","article-title":"Uncommon patterns of antinuclear antibodies recognizing mitotic spindle apparatus antigens and clinical associations","volume":"97","author":"Betancur","year":"2018","journal-title":"Medicine"},{"issue":"6","key":"10.1016\/j.clinbiochem.2021.01.008_b0010","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.autrev.2007.01.011","article-title":"The management of the patient with unexpected autoantibody positivity","volume":"6","author":"Bagnasco","year":"2007","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.clinbiochem.2021.01.008_b0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/14756360400021882","article-title":"Introduction autoantibodies \u2013 the smoke and the fire","volume":"38","author":"Shoenfeld","year":"2005","journal-title":"Autoimmunity"},{"issue":"10","key":"10.1016\/j.clinbiochem.2021.01.008_b0020","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.autrev.2013.03.014","article-title":"Prevalence and clinical significance of rare antinuclear antibody patterns","volume":"12","author":"Vermeersch","year":"2013","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.clinbiochem.2021.01.008_b0025","doi-asserted-by":"crossref","first-page":"53","DOI":"10.30621\/jbachs.2018.408","article-title":"Evaluation of rare antinuclear antibody patterns in a tertiary hospital in \u0130zmir","volume":"2","author":"Sener","year":"2018","journal-title":"J. Basic Clin. Health Sci."},{"key":"10.1016\/j.clinbiochem.2021.01.008_b0030","doi-asserted-by":"crossref","first-page":"412","DOI":"10.3389\/fimmu.2015.00412","article-title":"Report of the First International Consensus on Standardized Nomenclature of Antinuclear Antibody HEp-2 Cell Patterns 2014-2015","volume":"6","author":"Chan","year":"2015","journal-title":"Front. Immunol."},{"issue":"8","key":"10.1016\/j.clinbiochem.2021.01.008_b0035","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1177\/0961203316640920","article-title":"Report on the second International Consensus on ANA Pattern (ICAP) workshop in Dresden 2015","volume":"25","author":"Chan","year":"2016","journal-title":"Lupus"},{"key":"10.1016\/j.clinbiochem.2021.01.008_b0040","unstructured":"American College of Rheumatology Position Statement. Methodology of testing for antinuclear antibodies.www.rheumatologyorg\/practice\/ana_position_stmtpdf. Approved by Board of Directors: Aug 2011."},{"issue":"7","key":"10.1016\/j.clinbiochem.2021.01.008_b0045","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1136\/annrheumdis-2018-214436","article-title":"Clinical relevance of HEp-2 indirect immunofluorescent patterns: the International Consensus on ANA patterns (ICAP) perspective","volume":"78","author":"Damoiseaux","year":"2019","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.clinbiochem.2021.01.008_b0050","doi-asserted-by":"crossref","unstructured":"J. G\u03ccmez-Puerta, A. Londo\u00f1o, V.E. Estrada, S.L. Puerta, S.M. Osorno J.A. Carmona AB0956\u2005Atypical Patterns of Antinuclear Antibodies in Colombian General Population, Ann. Rheumatic Diseases, 2016;75:1228.","DOI":"10.1136\/annrheumdis-2016-eular.3763"},{"key":"10.1016\/j.clinbiochem.2021.01.008_b0055","doi-asserted-by":"crossref","first-page":"6911","DOI":"10.1038\/s41598-017-07137-4","article-title":"Anti-centromere antibody exhibits specific distribution levels among anti-nuclear antibodies and may characterize a distinct subset in rheumatoid arthritis","volume":"7","author":"Kuramoto","year":"2017","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.clinbiochem.2021.01.008_b0060","doi-asserted-by":"crossref","first-page":"689","DOI":"10.5114\/aoms.2017.67288","article-title":"Henoch-Sch\u00f6nlein purpura in a pediatric patient with lupus","volume":"13","author":"Hu","year":"2017","journal-title":"Arch Med Sci."},{"issue":"1","key":"10.1016\/j.clinbiochem.2021.01.008_b0065","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1586\/erm.11.82","article-title":"Antinuclear antibodies as ancillary markers in primary biliary cirrhosis","volume":"12","author":"Granito","year":"2012","journal-title":"Expert Rev. Mol. Diagn."},{"issue":"2","key":"10.1016\/j.clinbiochem.2021.01.008_b0070","doi-asserted-by":"crossref","first-page":"84","DOI":"10.4103\/0972-6691.178274","article-title":"Anti-centriole antibody: an infectious or autoimmune process?","volume":"29","author":"Saikia","year":"2015","journal-title":"Indian J Allergy Asthma Immunol."},{"key":"10.1016\/j.clinbiochem.2021.01.008_b0075","unstructured":"H.J. Worman, Nuclear envelope protein antigens. Hepatol. Res., 2007;37:S406-S411. doi: 10.111\/j.1872-034X.2007.00227.x."},{"issue":"3","key":"10.1016\/j.clinbiochem.2021.01.008_b0080","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.jaut.2010.06.019","article-title":"Antinuclear antibodies: a contemporary nomenclature using HEp-2 cells","volume":"35","author":"Wiik","year":"2010","journal-title":"J. Autoimmun."},{"issue":"6","key":"10.1016\/j.clinbiochem.2021.01.008_b0085","first-page":"415","article-title":"Clinical significance of cytoplasmic staining in antinuclear antibody tests using HEp-2 Cells","volume":"23","author":"Baek","year":"2003","journal-title":"Korean J. Lab. Med."},{"key":"10.1016\/j.clinbiochem.2021.01.008_b0090","doi-asserted-by":"crossref","unstructured":"S.J. Calise, G.D. Keppeke,, L.E.C. Andrade,, E.K.L. Chan, Anti-rods\/rings\u00a0: a human model of drug-induced autoantibody generation. vol. 6, no. February, pp. 5\u20139, 2015. Front. Immunol. 2015;6(41):5-9. doi: 10.3389\/fimmu.2015.00041.","DOI":"10.3389\/fimmu.2015.00041"},{"issue":"10","key":"10.1016\/j.clinbiochem.2021.01.008_b0095","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.autrev.2010.05.001","article-title":"Autoimmunity reviews anti-NuMA1 and anti-NuMA2 (anti-HsEg5) antibodies: clinical and immunological features: a propos of 40 new cases and review of the literature","volume":"9","author":"Szalat","year":"2010","journal-title":"Autoimmun. Rev."},{"issue":"4","key":"10.1016\/j.clinbiochem.2021.01.008_b0100","doi-asserted-by":"crossref","first-page":"151","DOI":"10.12691\/ijcd-3-4-8","article-title":"The world incidence and prevalence of autoimmune diseases is increasing","volume":"3","author":"Lerner","year":"2015","journal-title":"Int. J. Coeliac Dis."},{"key":"10.1016\/j.clinbiochem.2021.01.008_b0105","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1046\/j.1365-2141.2003.04587.x","article-title":"Prevalence and pattern of antinuclear autoantibodies in 347 patients with non-Hodgkin\u2019s lymphoma","volume":"123","author":"GuyomardS","year":"2003","journal-title":"Br. J. Hematol."},{"issue":"6","key":"10.1016\/j.clinbiochem.2021.01.008_b0110","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1590\/S0482-50042010000600006","article-title":"Clinical relevance and frequency of cytoplasmic and nuclear dense fine speckled patterns observed in ANA-HEp-2","volume":"50","author":"Pazini","year":"2010","journal-title":"Rev. Bras. Reumatol."},{"key":"10.1016\/j.clinbiochem.2021.01.008_b0115","doi-asserted-by":"crossref","unstructured":"H.A. Mariz, I. Sato, S.H. Barbosa, S.H. Rodrigues, A. Dellavance, L.E.C. Andrade, Pattern on the Antinuclear Antibody \u2013 HEp-2 Test Is a Critical Parameter for Discriminating Antinuclear Antibody \u2013 Positive Healthy Individuals and Patients With Autoimmune Rheumatic Diseases.2011;63(1):191\u2013200.","DOI":"10.1002\/art.30084"},{"key":"10.1016\/j.clinbiochem.2021.01.008_b0120","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1038\/ajg.2015.333","article-title":"Antibodies to mitotic apparatus: new association with cholestatic liver disease","volume":"110","author":"Pascual","year":"2015","journal-title":"Am. J. Gastroenterol."},{"issue":"12","key":"10.1016\/j.clinbiochem.2021.01.008_b0125","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1046\/j.1365-4362.2000.00109.x","article-title":"The diagnostic value of anti-nuclear antibody testing","volume":"39","author":"Adams","year":"2000","journal-title":"Int. J. Dermatol."},{"key":"10.1016\/j.clinbiochem.2021.01.008_b0130","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/ajh.20188","article-title":"Autoimmune cytopenias associated with autoantibodies to nuclear envelope polypeptides","volume":"77","author":"Coppo","year":"2004","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.clinbiochem.2021.01.008_b0135","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1055\/s-2007-1007183","article-title":"Antimitochondrial antibodies in primary biliary cirrhosis","volume":"17","author":"Leung","year":"1997","journal-title":"Semin. Liver Dis."},{"issue":"3","key":"10.1016\/j.clinbiochem.2021.01.008_b0140","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0896-8411(03)00033-7","article-title":"Profile and clinical significance of anti-nuclear envelope antibodies found in patients with primary biliary cirrhosis: a multicenter study","volume":"20","author":"Miyachi","year":"2003","journal-title":"J. Autoimmun."},{"issue":"4","key":"10.1016\/j.clinbiochem.2021.01.008_b0145","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.autrev.2010.09.025","article-title":"Historical perspectives on the discovery and elucidation of autoantibodies to centromere proteins (CENP) and the emerging importance of antibodies to CENP-F","volume":"10","author":"Fritzler","year":"2011","journal-title":"Autoimmun. Rev."},{"issue":"4","key":"10.1016\/j.clinbiochem.2021.01.008_b0150","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1093\/rheumatology\/32.4.297","article-title":"Patients with anticentromere antibodies, clinical features, diagnoses and evolution","volume":"32","author":"Vlachoyiannopoulos","year":"1993","journal-title":"Br. J. Rheumatol."},{"issue":"5","key":"10.1016\/j.clinbiochem.2021.01.008_b0155","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1007\/s10875-006-9038-y","article-title":"Autoantibodies to mitotic apparatus: association with other autoantibodies and their clinical significance","volume":"26","author":"Bonaci-nikolic","year":"2006","journal-title":"J. Clin. Immunol."},{"issue":"5","key":"10.1016\/j.clinbiochem.2021.01.008_b0160","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1053\/sarh.2001.20266","article-title":"Anti-nuclear envelope antibodies: clinical associations","volume":"30","author":"Nesher","year":"2001","journal-title":"Semin. Arthritis Rheum."}],"container-title":["Clinical Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912021000242?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912021000242?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T20:09:59Z","timestamp":1762114199000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009912021000242"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":32,"alternative-id":["S0009912021000242"],"URL":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2021.01.008","relation":{},"ISSN":["0009-9120"],"issn-type":[{"value":"0009-9120","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Uncommon antinuclear antibody patterns as diagnostic indicators","name":"articletitle","label":"Article Title"},{"value":"Clinical Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2021.01.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}